FranciscoVegaMD

Vascular Endovascular Surgeon UCR General Surgery Residency Teaching Faculty

Dr. Vega is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
7300 Magnolia Ave
Riverside, CA 92504
Phone+1 951-278-8870

Fax+1 951-278-8913

Dr. Francisco Vega is a vascular surgeon in Riverside, CA and is affiliated with multiple hospitals in the area, including Riverside Community Hospital, Corona Regional Medical Center, and Barstow Community Hospital. He received his medical degree from Meharry Medical College School of Medicine and has been in practice 8 years. He is experienced in peripheral vascular disease, lower extremity amputations, dialysis access placement, peritoneal dialysis, and lower extremity venous thomboses. He has more than 80 publications and over 500 citings.

Baylor University Medical CenterFellowship, Vascular Surgery - Independent, 2018 - 2020
Riverside University Health System/University of California RiversideResidency, Surgery, 2013 - 2018
Meharry Medical CollegeClass of 2012

PubMed

31 citations
Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma
Preetesh Jain, Shuangtao Zhao, Hun Ju Lee, Holly Hill, Chi Young Ok
Journal of Clinical Oncology. 2021-11-19
23 citations
Cardiovascular events in patients treated with chimeric antigen receptor t-cell therapy for aggressive B-cell lymphoma.
Raphael E Steiner, Jose Banchs, Efstratios Koutroumpakis, Melody R. Becnel, Cristina Gutierrez
Haematologica. 2021-11-11
2 citations
Mantle Cell Lymphoma with Chronic Lymphocytic Leukemia-Like Features: A Diagnostic Mimic and Pitfall.
Lianqun Qiu, Jie Xu, Guilin Tang, Sa A. Wang, Pei Lin
Human Pathology. 2021-11-09

$Confronting Knowledge Gaps Concerning Relapsed/Refractory Follicular Lymphoma$
Confronting Knowledge Gaps Concerning Relapsed/Refractory Follicular LymphomaJune 22nd, 2022